ホーム › 前立腺がん › ミシガン州 › Ann Arbor
Ann Arbor、MIにおける前立腺がんの臨床試験
Ann Arborとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する27件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
被験者募集中第3相
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15マイル先
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18マイル先
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
被験者募集中第3相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- 他4件
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
被験者募集中第2相
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15マイル先
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18マイル先
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
被験者募集中第2相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- 他4件
Precision-Based Genomics in Prostate Cancer
被験者募集中観察研究
- University of Michigan, Ann Arbor
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
被験者募集中第1/2相
- Research Site, Ann Arbor
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
被験者募集中第2相
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
被験者募集中第3相
- University of Michigan ( Site 0005), Ann Arbor
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
被験者募集中第3相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Chelsea Hospital, Chelsea · 15マイル先
- 他2件
Prostate Active Surveillance Study
被験者募集中観察研究
- University of Michigan, Ann Arbor
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
被験者募集中観察研究
- Rogel Cancer Center, Ann Arbor
EDRN Prostate MRI Biomarker Study
被験者募集中観察研究
- University of Michigan, Ann Arbor
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
被験者募集中第2相
- University of Michigan Health, Ann Arbor
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
被験者募集中観察研究
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
被験者募集中第3相
- Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18マイル先
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
被験者募集中第2相
- VA Ann Arbor Healthcare System, Ann Arbor
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
被験者募集中観察研究
- University of Michigan Rogel Cancer Center, Ann Arbor
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1/2相
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
被験者募集中第2/3相
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
被験者募集中第3相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- 他4件
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
被験者募集中
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
被験者募集中第2相
- University of Michigan Rogel Cancer Center, Ann Arbor
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
被験者募集中第2相健康なボランティア歓迎
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
被験者募集中観察研究
- University of Michigan Rogel Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Ann Arbor
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Saint Joseph Mercy Chelsea, Chelsea · 15マイル先
- 他1件
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN42件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
Ann Arborにおける他の研究
- 乳がん26件の研究
- 非小細胞肺癌26件の研究
- がん（全種類）25件の研究
- 大腸癌23件の研究
- 肺がん23件の研究
- 心不全22件の研究
- 急性骨髄性白血病17件の研究
- 心血管疾患16件の研究
- 膵臓がん14件の研究
- 悪性黒色腫12件の研究
- 腎臓がん（腎細胞がん）12件の研究
- 頭頸部扁平上皮癌12件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。